Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advitech, Inc.
Marketing program stepped up for new oral psoriasis product
August 10th, 2005
Advitech, Inc., (AVI), a Canadian biotech company, announced two key initiatives aimed at stepping up its marketing program for the company's new oral product for treating psoriasis. The company recently announced positive results from a double blind, placebo controlled clinical study demonstrating the efficacy and safety of XP-828L, its oral product for mild-to-moderate psoriasis. Advitech announced that it has retained the services of Navigant Consulting, Inc., to help develop and execute its strategic marketing program for XP-828L. Navigant, a U.S.-based consulting firm with specialized services in the biotech and healthcare sectors, just...
Source: Biotech Week (2005-08-10)
|
